0001705381-17-000001.txt : 20170503 0001705381-17-000001.hdr.sgml : 20170503 20170503151841 ACCESSION NUMBER: 0001705381-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170503 DATE AS OF CHANGE: 20170503 EFFECTIVENESS DATE: 20170503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CeleCor Therapeutics, Inc. CENTRAL INDEX KEY: 0001705381 IRS NUMBER: 870723255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-285981 FILM NUMBER: 17808865 BUSINESS ADDRESS: STREET 1: 4963 HIDDEN DUNE COURT CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-777-9750 MAIL ADDRESS: STREET 1: 4963 HIDDEN DUNE COURT CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0707 D LIVE 0001705381 CeleCor Therapeutics, Inc. 4963 HIDDEN DUNE COURT SAN DIEGO CA CALIFORNIA 92130 858-777-9750 DELAWARE None None Corporation true 2017 Robert S. Hillman 4963 Hidden Dune Court San Diego CA CALIFORNIA 92130 Executive Officer Director President, Director & Treasurer Andreas Ritzi 4963 Hidden Dune Court San Diego CA CALIFORNIA 92130 Director Caspar F.V. Sturm 4963 Hidden Dune Court San Diego CA CALIFORNIA 92130 Director Peter B. Finn 50 Rowes Wharf Boston MA MASSACHUSETTS 02110 Executive Officer Secretary Biotechnology Decline to Disclose 06b false 2017-04-27 false true false 500000 25000000 0 25000000 $6,000,000.00 (six million) of the offering was paid into the issuer at the closing on April 27, 2017. The $19,000,000.00 (nineteen million) balance is due upon the occurrence of mutually agreed upon milestones. false 5 0 0 0 true false CeleCor Therapeutics, Inc. Peter B. Finn Peter B. Finn Secretary 2017-05-03